Hightower 6 M Holding, LLC Eagle Pharmaceuticals, Inc. Transaction History
Hightower 6 M Holding, LLC
- $1.11 Billion
- Q3 2022
A detailed history of Hightower 6 M Holding, LLC transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Hightower 6 M Holding, LLC holds 8,862 shares of EGRX stock, worth $17,192. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,862
Previous 9,115
2.78%
Holding current value
$17,192
Previous $405,000
42.22%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding EGRX
# of Institutions
8Shares Held
438KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY353KShares$684,3580.0% of portfolio
-
Ajo Vista, LLC Boston, MA56.4KShares$109,4890.92% of portfolio
-
Stanley Laman Group, Ltd. Berwyn, PA12KShares$23,2800.0% of portfolio
-
Acadian Asset Management LLC Boston, MA7.16KShares$13,8800.0% of portfolio
-
Wipfli Financial Advisors Llc,661Shares$1,2820.0% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $25.3M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...